20 employees
Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale.
2019
$4.1M
from 3 investors over 3 rounds
Model Medicines raised $4.1M on February 1, 2021
Investors: Irving Investors, 8VC and ParticleX